XTNT
Xtant Medical Holdings Inc (XTNT)
Healthcare • NYSE MKT • $0.52-8.77%
- Symbol
- XTNT
- Exchange
- NYSE MKT
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $0.52
- Daily Change
- -8.77%
- Market Cap
- $72.84M
- Trailing P/E
- 17.33
- Forward P/E
- -26.00
- 52W High
- $0.95
- 52W Low
- $0.44
- Analyst Target
- $1.10
- Dividend Yield
- N/A
- Beta
- -0.12
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structur…
Company websiteResearch XTNT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.